Companies: 10,795·Total market cap: $144.5T
InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

INMNASDAQHealthcare● Active
$1.54
$-0.04(-2.53%)
Market Cap$2787286
P/E Ratio—
52W High$5.5
52W Low$0.575
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

InMed Pharmaceuticals Inc. (INM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001728328 · INM · NASDAQ · as of Jun 8, 2026

Filing snapshot

478
Total Filings
SCHEDULE 13G
Latest Form
2026-06-05
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001728328 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-10-24
Fiscal Year End
Oct 24, 2025
Accession No.
0001213900-25-102157
Primary Document
ea0262392-10ka1_inmed.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001728328 · Accession 0001213900-25-102157

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
CURRENT REPORT
2026-05-19Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-06-05
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-27
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-21
View
425425
CURRENT REPORT
2026-05-19
View
8-KCurrent Report
CURRENT REPORT
2026-05-19
View
8-KCurrent Report
FORM 8-K
2026-05-19
View
8-KCurrent Report
FORM 8-K
2026-05-07
View
10-QQuarterly Report
QUARTERLY REPORT
2026-05-06
View
8-KCurrent Report
CURRENT REPORT
2026-04-27
View
8-KCurrent Report
CURRENT REPORT
2026-04-03
View
424B5424B5
PROSPECTUS SUPPLEMENT
2026-04-03
View
EFFECTEFFECT
EFFECT
2026-03-30
View
8-KCurrent Report
FORM 8-K
2026-03-30
View
CORRESPCORRESP
CORRESP
2026-03-26
View
UPLOADUPLOAD
UPLOAD
2026-03-25
View
Showing 1–15 of 365 filingsForm 4 / 144 hidden· 478 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001728328  |  Exchange: NASDAQ · Healthcare

InMed Pharmaceuticals Inc. (NASDAQ: INM) has submitted 478 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001728328, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is InMed Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent InMed Pharmaceuticals Inc. 10-K was filed on 2025-10-24 for fiscal year ending 2025. Historical INM 10-K annual reports are available from 2018 through 2025.

Investors researching InMed Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ESLA SEC Filings →KZIA SEC Filings →BIVI SEC Filings →SILO SEC Filings →CNSP SEC Filings →GLMD SEC Filings →GNPX SEC Filings →GRI SEC Filings →
→ INM Financials→ INM Earnings→ INM Insider Trades

Frequently Asked Questions

INM SEC Filings · 8 questions

InMed Pharmaceuticals Inc. (INM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 478 filings and access original documents at no cost. InMed Pharmaceuticals Inc.'s CIK is 0001728328.

INM SEC filingsInMed Pharmaceuticals Inc. SEC documentsfind INM 10-K